Edward L. Murphy, MPH, MD

Education

Professional Experience

• 1974-1976
  Research in human deep-sea diving physiology, COMEX Diving Company, Marseille,France
• 1981-1984
  Resident in Internal Medicine, Boston University Medical Center, Boston, MA
• 1984-1988
  Medical Staff Fellow, National Cancer Institute, Bethesda, MD
• 1986
  Honorary Lecturer, University Hospital of the West Indies, Kingston, JA
• 1988-2001
  Attending physician, AIDS Clinic, San Francisco General Hospital
• 1988-1994
  Assistant Professor, Departments of Laboratory Medicine, Medicine, and Epidemiology/Biostatistics, University of California, San Francisco, CA
• 1994-2000
  Associate Professor, Departments of Laboratory Medicine, Medicine, and Epidemiology/Biostatistics, University of California, San Francisco, CA
• 1995-1996
  Visiting Researcher, Institut Pasteur, Paris, France
• 2000-present
  Professor, Departments of Laboratory Medicine and Epidemiology/Biostatistics, University of California San Francisco

Honors & Awards

• 1970
  Westinghouse Scholarship
• 1980-81
  University of California Graduate Scholarship
• 1984
  Chateaubriand prize of the French Government
• 1984
  International Agency for Cancer Research Fellowship (declined)
• 1988
  FDA Commissioners Special Citation
• 1989-92
  Charles E. Culpeper Scholarship
• 1995-96
  Fulbright Scholarship, France
• 1995-96
  NIH Fogarty Senior International Fellowship
• 2003
  President, International Retrovirology Association

Selected Publications

1. Estrada FGMD, Oliveira CDL, Sabino EC, Custer B, Gonçalez TT, Murphy EL, Teles D, Mendrone-Junior A, Witkin SS, de Almeida-Neto C. Are different motivations and social capital score associated with return behaviour among Brazilian voluntary non-remunerated blood donors? Transfus Med. 2020 May 28.
   View on PubMed
2. Tagny CT, Bissim M, Djeumen R, Ngo Sack F, Angandji P, Ndoumba A, Kouanfack C, Eno L, Mbanya D, Murphy EL, Laperche S. The use of the GeeniusTM HIV-1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa. Vox Sang. 2020 May 28.
   View on PubMed
3. Bruhn R, Karafin MS, Hilton JF, Kaidarova Z, Spencer BR, Qu L, Snyder EL, Olin R, Murphy EL, St Lezin E. Early and sustained improvement in fatigue-related quality of life following red blood cell transfusion in outpatients. Qual Life Res. 2020 May 07.
   View on PubMed
4. Bloch EM, Hull J, Green-Thompson R, Ingram C, Crookes RL, Fawcus S, Anthony J, Courtney L, Roubinian N, Jauregui A, Hilton JF, Murphy EL. Antenatal blood transfusion in South Africa: indications and practice in a high-HIV-prevalence setting. Transfusion. 2020 Mar; 60(3):479-487.
   View on PubMed
5. Gottschall J, Wu Y, Triulzi D, Kleinman S, Strauss R, Zimrin AB, McClure C, Tan S, Bialkowski W, Murphy E, Ness P. The epidemiology of platelet transfusions: an analysis of platelet use at 12?US hospitals. Transfusion. 2020 Jan; 60(1):46-53.
   View on PubMed
6. Candotti D, Sauvage V, Cappy P, Boullahi MA, Bizimana P, Mbensa GO, Oumar Coulibaly S, Rakoto Alson AO, Soumana H, Tagny-Tayou C, Murphy EL, Laperche S. High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply. Transfusion. 2020 Jan; 60(1):106-116.
   View on PubMed
7. Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Blood Transfus. 2019 11; 17(6):403-408.
   View on PubMed
8. Drammeh B, Laperche S, Hilton JF, Kaidarova Z, Ozeryansky L, De A, Kalou M, Benech I, Parekh B, Murphy EL. Proficiency Testing of Viral Marker Screening in African Blood Centers - Seven African Countries, 2017. MMWR Morb Mortal Wkly Rep. 2019 Oct 25; 68(42):947-952.
   View on PubMed
9. Roubinian NH, Westlake M, St Lezin EM, Edgren G, Brambilla DJ, Lee C, Bruhn R, Cable RG, Triulzi DJ, Glynn SA, Kleinman S, Murphy EL. Association of donor age, body mass index, hemoglobin, and smoking status with in-hospital mortality and length of stay among red blood cell-transfused recipients. Transfusion. 2019 11; 59(11):3362-3370.
   View on PubMed
10. Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Blood Transfus. 2019 Sep 24; 1-6.
    View on PubMed
11. Roubinian N, Kleinman S, Murphy EL, Glynn SA, Edgren G. Methodological considerations for linked blood donor-component-recipient analyses in transfusion medicine research. ISBT Sci Ser. 2020 Feb; 15(1):185-193.
    View on PubMed
12. Roubinian NH, Plimier C, Woo JP, Lee C, Bruhn R, Liu VX, Escobar GJ, Kleinman SH, Triulzi DJ, Murphy EL, Busch MP. Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion. Blood. 2019 09 26; 134(13):1003-1013.
    View on PubMed
13. Sykes W, Van den Berg K, Jacobs G, Jauregui A, Roubinian N, Wiesner L, Maartens G, Swanevelder R, Custer B, Busch M, Jentsch U, Murphy EL, Vermeulen M. Discovery of False Elite Controllers: HIV Antibody-Positive RNA-Negative Blood Donors Found To Be on Antiretroviral Therapy. J Infect Dis. 2019 07 19; 220(4):643-647.
    View on PubMed
14. Swanevelder R, Reddy R, Chowdhury D, Olmsted M, Brambilla D, Jentsch U, Murphy EL. Using a motivator and deterrent questionnaire to predict actual donation return behavior among first-time African-origin blood donors. Transfusion. 2019 09; 59(9):2885-2892.
    View on PubMed
15. Karafin MS, Bruhn R, Roubinian NH, Chowdhury D, Qu L, Snyder EL, Murphy EL, Brambilla D, Cable RG, Hilton JF, St Lezin E. The impact of recipient factors on the lower-than-expected hemoglobin increment in transfused outpatients with hematologic diseases. Transfusion. 2019 08; 59(8):2544-2550.
    View on PubMed
16. Edgren G, Murphy EL, Brambilla DJ, Westlake M, Rostgaard K, Lee C, Cable RG, Triulzi D, Bruhn R, St Lezin EM, Erikstrup C, Ullum H, Glynn SA, Kleinman S, Hjalgrim H, Roubinian NH. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients. JAMA. 2019 06 11; 321(22):2183-2192.
    View on PubMed
17. Gonçalez TT, Sabino EC, Kaidarova Z, Carneiro-Proietti ABF, Miranda C, Loureiro P, Lopes ME, de Almeida-Neto C, Schlumpf KS, Wright DJ, Murphy EL, Custer B. Does deferral for high-risk behaviors improve the safety of the blood supply? Transfusion. 2019 07; 59(7):2334-2343.
    View on PubMed
18. Mitchel J, Custer B, Kaidarova Z, Murphy EL, van den Berg K. Implementation of a script for predonation interviews: impact on human immunodeficiency virus risk in South African blood donors. Transfusion. 2019 07; 59(7):2344-2351.
    View on PubMed
19. Vermeulen M, Sykes W, Coleman C, Custer B, Jacobs G, Jaza J, Kaidarova Z, Hlela C, Gessain A, Cassar O, Poole C, Ingram C, Murphy EL, Reddy R. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors. Vox Sang. 2019 Jul; 114(5):451-458.
    View on PubMed
20. St Lezin E, Karafin MS, Bruhn R, Chowdhury D, Qu L, Bialkowski W, Merenda S, D'Andrea P, McCalla AL, Anderson L, Keating SM, Stone M, Snyder EL, Brambilla D, Murphy EL, Norris PJ, Hilton JF, Spencer BR, Kleinman S, Carson JL. Therapeutic impact of red blood cell transfusion on anemic outpatients: the RETRO study. Transfusion. 2019 06; 59(6):1934-1943.
    View on PubMed

Go to UCSF Profiles, powered by CTSI